Revenio Group Corporation: REVENIO TO DIVEST ITS OPERATIONS IN THE TECHNOLOGY AND SERVICES SEGMENT AND TRANSFER THEM TO AVAILABLE-FOR-SALE DISCONTINUED OPERATIONS

Revenio Group Corporation Stock Exchange Release, December 1, 2014 at 9:00 am


REVENIO TO DIVEST ITS OPERATIONS IN THE TECHNOLOGY AND SERVICES SEGMENT AND
TRANSFER THEM TO AVAILABLE-FOR-SALE DISCONTINUED OPERATIONS

Today, the Board of Directors of Revenio Group Corporation has decided to divest
Boomeranger Boats Oy and Done Software Solutions Oy, which represent its
Technology and Services segment, and to transfer said companies to available-
for-sale discontinued operations. According to the plans of Revenio's
management, the sale of these companies will be carried out within a year of the
classification decision in accordance with IFRS 5.8. These business operations
will be sold due to Revenio's strategic focus on health tech and the related
divestment of non-core operations. At the same time, Revenio has decided to
write down Boomeranger Boats Oy's goodwill, about EUR 3.1 million.

In operational terms, the companies will continue to operate as usual and the
arrangement does not have an effect on the current or future customer
relationships of these businesses. The arrangement is part of the Revenio
Group's strategic focus on health tech.

Boomeranger Boats Oy and Done Software Solutions Oy, which represent the
Technology and Services segment and will be transferred to avalable-for-sale
discontinued operations, had net sales of EUR 6,8 million and an operating
result of EUR 0,6 million in 2013.

Revenio Group Corporation
Olli-Pekka Salovaara
President & CEO

For additional information, please contact
President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520
olli-pekka.salovaara@revenio.fi
www.revenio.fi


DISTRIBUTION:
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi

The Revenio Group in brief
Revenio is a Finnish health tech group whose core business lies in tonometers.
The Revenio Health Tech segment comprises the business operations of Icare
Finland Oy and Oscare Medical Oy. The widely patented Icare product family is
the current cornerstone of the Group's success. Revenio seeks vigorous growth in
health technology, both organically and through acquisitions and mergers.

The Revenio Group also includes other business operations, which are grouped
under the Technology and Services segment. This segment's operations have a
shared global market and represent the cutting edge of technology products and
services in their industry.

In 2013, the Revenio Group's net sales totaled EUR 25.7 million, with its
operating margin standing at 21.7%. The Revenio Group Corporation is listed on
NASDAQ OMX Helsinki.




[HUG#1875488]